Nova Eye Medical Limited (OTCPK:ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device November 25, 2025 5:30 PM EST Company Participants Mark Flynn - Investor Relations Thomas Spurling - MD & Executive Director Conference Call Participants Dr. Mahmoud Khaimi Presentation Mark Flynn Investor Relations Good morning, everyone, and thank you for joining us at Nova Eye. We're here to walk you through the clinical use of the iTrack Advance and share some direct insights from the field.
Nova Ltd. ( NVMI ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Gabriel Waisman - President & CEO Guy Kizner - Chief Financial Officer Conference Call Participants Miri Segal-Scharia - MS-IR LLC Atif Malik - Citigroup Inc., Research Division Ezra Weener - Jefferies LLC, Research Division Vedvati Shrotre - Evercore ISI Institutional Equities, Research Division Yu Shi - Needham & Company, LLC, Research Division Presentation Operator Good morning, and welcome to Nova's Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Nova Minerals is transitioning from exploration to development, relying on capital raises with a limited cash runway and no commercial revenues yet. The Estelle Gold & Critical Minerals Project, especially the RPM and Korbel deposits, is central to NVA's future, with antimony adding strategic value. Securing a land use permit for an antimony refinery at Port MacKenzie marks a shift toward vertical integration and potential US defense sector involvement.
Nova Ltd. has quietly outperformed in the semiconductor equipment sector over the past two years. Despite peers like KLA and Lam Research drawing more attention, NVMI has delivered superior returns. NVMI's success is driven by its ability to consistently gain market share in the industry.
Nova Ltd. (NASDAQ:NVMI ) Citi's 2025 Global Technology, Media and Telecommunications Conference September 4, 2025 3:30 PM EDT Company Participants Gabriel Waisman - President & CEO Conference Call Participants Atif Malik - Citigroup Inc., Research Division Presentation Atif Malik Director and Semiconductor Capital Equipment & Specialty Semiconductor Analyst Good afternoon, everyone. Welcome to day 2 of Citi Global TMT Conference.
The Bank of Nova Scotia delivered a strong Q3, beating analyst expectations with 13.5% revenue growth and 15% higher adjusted earnings year-over-year. The bank's turnaround plan is progressing, focusing on shedding weaker international assets and emphasizing growth in Canada, the U.S., and Mexico. Canadian Banking results were mixed, with higher expenses and lower net interest margins, but return on equity rebounded to 18.4%.
NVFY's second-quarter 2025 loss narrows on improved margins, while sales dip due to continued furniture sector challenges.
NVMI shares rise as second-quarter earnings and revenues beat estimates, with upbeat Q3 guidance fueling investor optimism.
Nova Ltd. (NASDAQ:NVMI ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Gabriel Waisman - President & CEO Guy Kizner - Chief Financial Officer Conference Call Participants Atif Malik - Citigroup Inc., Research Division Ezra Gabriel Weener - Jefferies LLC, Research Division Matthew Patrick Prisco - Cantor Fitzgerald & Co., Research Division Michael Sebastian Mani - BofA Securities, Research Division Yu Shi - Needham & Company, LLC, Research Division Miri Segal-Scharia - MS-IR LLC Operator Welcome to the Nova Limited Second Quarter 2025 Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Nova Ltd. (NVMI) came out with quarterly earnings of $2.2 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $1.61 per share a year ago.
NVMI's Q2 results are likely to reflect AI-driven demand and metrology growth.
Scotiabank's strong balance sheet, diversified assets, and high capital ratios provide resilience and support long-term dividend sustainability. Prudent loan portfolio management, especially the fixed/variable mortgage split, positions BNS well for both current and future interest rate environments. Valuation remains attractive, with the stock trading below historical P/B averages and offering a solid 5.8% dividend yield with upside potential.